Larson Financial Group’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $51.3K | Sell |
2,105
-150
| -7% | -$3.65K | ﹤0.01% | 1059 |
|
|
2025
Q1 | $46.8K | Sell |
2,255
-302
| -12% | -$6.27K | ﹤0.01% | 1044 |
|
|
2024
Q4 | $60.2K | Sell |
2,557
-262
| -9% | -$6.17K | ﹤0.01% | 843 |
|
|
2024
Q3 | $72.2K | Sell |
2,819
-501
| -15% | -$12.8K | ﹤0.01% | 796 |
|
|
2024
Q2 | $77.9K | Buy |
3,320
+3,249
| +4,576% | +$76.3K | 0.01% | 708 |
|
|
2024
Q1 | $2.04K | Hold |
71
| – | – | ﹤0.01% | 1353 |
|
|
2023
Q4 | $2.33K | Sell |
71
-333
| -82% | -$10.9K | ﹤0.01% | 1342 |
|
|
2023
Q3 | $11.3K | Hold |
404
| – | – | ﹤0.01% | 963 |
|
|
2023
Q2 | $13.8K | Sell |
404
-344
| -46% | -$11.7K | ﹤0.01% | 840 |
|
|
2023
Q1 | $22.5K | Sell |
748
-18
| -2% | -$541 | ﹤0.01% | 712 |
|
|
2022
Q4 | $21.6K | Buy |
766
+125
| +20% | +$3.53K | ﹤0.01% | 679 |
|
|
2022
Q3 | $21K | Hold |
641
| – | – | ﹤0.01% | 618 |
|
|
2022
Q2 | $20K | Hold |
641
| – | – | ﹤0.01% | 545 |
|
|
2022
Q1 | $29K | Sell |
641
-280
| -30% | -$12.7K | ﹤0.01% | 461 |
|
|
2021
Q4 | $56K | Buy |
921
+328
| +55% | +$19.9K | 0.01% | 366 |
|
|
2021
Q3 | $44K | Hold |
593
| – | – | 0.01% | 318 |
|
|
2021
Q2 | $55K | Hold |
593
| – | – | 0.01% | 262 |
|
|
2021
Q1 | $53K | Buy |
+593
| New | +$53K | 0.02% | 248 |
|